Negative pressure wound therapy (NPWT) is a widely accepted modality in the treatment of complex wounds. While there have been many important developments with NPWT, there has been little, if any, innovation to the way NPWT is delivered and controlled at the wound bed and the manner in which fluid removal is managed. Additionally, there are fundamental requirements, not included in all currently available NPWT systems, that must be met in order to realize its full clinical benefits. The objectives of this presentation are to discuss the results of a recent publication comparing the ability of System A (Invia® Liberty™ NPWT System, Medela AG) and System B (V.A.C.ULTA™ Therapy System, 3M+KCI) to deliver set levels of NPWT to the wound bed and simultaneously manage volumes of simulated wound fluid.
Learning Objectives: Review the mode of action of negative pressure wound therapy (NPWT). Discuss the fundamental requirements of NPWT systems to deliver clinical benefits. Compare the ability of System A and System B to deliver set levels of NPWT and manage fluid volumes.
This Innovation Theater is sponsored by Medela
Innovation Theaters are non-accredited and no CME/CE credits are offered at these programs.